New Medication for Osteoarthritis Knee Pain Request More Information Trial Objective The purpose of this trial is to determine if a new FDA-approved medication called Hymovis™ is effective in reducing or eliminating pain in people with osteoarthritis in their knee. The medication will be injected into the participant’s knee using a pneumatic external compression device called KneeTap™ guided by ultrasound. This study will determine how the knee joint fluid proteins react to this medication to help reduce cartilage loss and joint pain. Enrollment This trial is active and currently recruiting. How to Participate For more information, contact Mary Gill at 303.398.1473, or complete the form below. Who Can Participate Patients who have an x-ray confirming mild to moderate osteoarthritis in the knee. Participants must not have had a knee infection or knee surgery within 12 months or a cortisone injection within 3 months of starting the study. Participants must be able to walk six minutes without a cane or walker. Estimated Time Commitment 5 visits over 12 months Trial Location National Jewish Main Campus, Denver, CO Compensation Provided Trial Sponsors Fidia Age 21-80 Gender Any Gender Principal Investigators Richard Meehan, MD, FACP + × Richard Meehan, MD, FACP Professor, Department of Medicine Division of Rheumatology Co-Director, Post-Deployment Lung Health Center Autoimmune Lung Center View Full Profile Make an Appoinment Co-Investigators Elizabeth Regan, MD, PhD + × Elizabeth Regan, MD, PhD Associate Professor Department of Medicine Division of Rheumatology View Full Profile Make an Appoinment Isabelle Amigues, MD, MS, RhMSUS + × Isabelle Amigues, MD, MS, RhMSUS Assistant Professor Department of Medicine Division of Rheumatology View Full Profile Patient Rating 4.7 out of 5 stars Make an Appoinment James Crooks, PhD, MS + × James Crooks, PhD, MS Assistant Professor Boettcher Investigator Office of Academic Affairs Division of Biostatistics and Bioinformatics View Full Profile Make an Appoinment Liudmila Kastsianok, MD + × Liudmila Kastsianok, MD Assistant Professor Department of Medicine Division of Rheumatology View Full Profile Patient Rating 4.6 out of 5 stars Make an Appoinment Request More Information First Name: * Last Name: * Email Address: * Phone: *
Trial Objective The purpose of this trial is to determine if a new FDA-approved medication called Hymovis™ is effective in reducing or eliminating pain in people with osteoarthritis in their knee. The medication will be injected into the participant’s knee using a pneumatic external compression device called KneeTap™ guided by ultrasound. This study will determine how the knee joint fluid proteins react to this medication to help reduce cartilage loss and joint pain.